par prism | Oct 10, 2021 | Study
The PRISM-I trial promoted by Gustave Roussy and Prism began on October 5, 2021. The objectives of this study are to: i. define the effectiveness of anti-PDL1 antibodies at 6 weeks, ii. decipher the immune response at the single cell and spatial level. 200 patients...
par prism | Sep 9, 2020 | News, Study
Chromosomal instability is a phenomenon present in most cancers and characterized by the gain or loss of chromosomes as well as structural changes in these chromosomes. This instability results in a somatic alteration of the number of copies which would be the...
par prism | Août 7, 2020 | Study
A study conducted by researchers and from Gustave Roussy, Assistance Publique – Hôpitaux de Paris AP-HP, Inserm, Université Paris-Saclay and Université de Paris, in collaboration with teams from Singapore, China and Israel, reveals that patients with severe form of...
Recent Comments